NCT02643316

Brief Summary

Comparison of quality of preparation of colonoscopy in patients taking same day 4L preparation vs. 4 L split dose preparation in patients scheduled for an afternoon colonoscopy procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

December 29, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 31, 2015

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

December 4, 2019

Status Verified

December 1, 2019

Enrollment Period

3.7 years

First QC Date

December 29, 2015

Last Update Submit

December 3, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of preparation (Ottawa score)

    The quality of bowel preparation will be assessed for the 2 groups at the time of the colonoscopy using the Ottawa score for quality of preparation.

    During the colonoscopy

Secondary Outcomes (1)

  • Patient satisfaction with the bowel preparation (questionnaire).

    Before the colonoscopy procedure.

Study Arms (2)

Same day 4 L preparation of PEG

ACTIVE COMPARATOR

Receive 1 gallon (4 L) of Polyethylene Glycol (PEG) preparation on the morning of the colonoscopy.

Drug: Same day 4 L preparation (Polyethylene Glycol)

Split dose 4 L preparation of of the PEG

ACTIVE COMPARATOR

Receive the split-dose regimen. Will take half (2 L) of the PEG preparation the evening before colonoscopy and half (2 L) of the PEG preparation on the morning of the procedure.

Drug: Split dose 4 L preparation (Polyethylene Glycol)

Interventions

Receive 1 gallon (4 L) of Polyethylene Glycol preparation on the morning of the colonoscopy.

Also known as: PEG bowel prep
Same day 4 L preparation of PEG

Receive the split-dose regimen. Will take half (2 L) the preparation the evening before colonoscopy and half (2 L) on the morning of the procedure.

Also known as: PEG bowel prep
Split dose 4 L preparation of of the PEG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. All patients above 18 years of age undergoing elective outpatient colonoscopy at CCF Florida who are scheduled for an afternoon colonoscopy procedure. All patients must have been prescribed a 4 L PEG based bowel preparation.

You may not qualify if:

  • Patients who had prior Colectomy or colon resection surgery.
  • Patients with confirmed diagnosis of impaired GI motility.
  • Chronic nausea or vomiting.
  • Severe constipation (=/\<1 bowel movement per week).
  • Pregnancy.
  • Breast feeding.
  • Patients taking drugs which are known to influence GI motility.
  • Hospital inpatients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Florida

Weston, Florida, 33331, United States

Location

Related Publications (1)

  • Castro FJ, Al-Khairi B, Singh H, Mohameden M, Tandon K, Lopez R. Randomized Controlled Trial: Split-dose and Same-day Large Volume Bowel Preparation for Afternoon Colonoscopy Have Similar Quality of Preparation. J Clin Gastroenterol. 2019 Nov/Dec;53(10):724-730. doi: 10.1097/MCG.0000000000001213.

MeSH Terms

Interventions

Polyethylene Glycols

Intervention Hierarchy (Ancestors)

Ethylene GlycolsGlycolsAlcoholsOrganic ChemicalsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Fernando Castro, M.D.

    Cleveland Clinic Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician

Study Record Dates

First Submitted

December 29, 2015

First Posted

December 31, 2015

Study Start

December 1, 2015

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

December 4, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations